A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic prostate biopsies outperformed the standard approach of ...

As reports surface that the UK’s national screening committee are set to reject proposals for any national prostate screening programme, experts warn that the decision, if followed through with, puts ...

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer should be screened for the disease. There is currently no screening programme ...

Here’s a number that should make you uncomfortable: Black men are 67% more likely to develop prostate cancer than white men. But wait, it gets worse. They’re also twice as likely to die from it. If ...

Genetic screening for prostate cancer can help identify inherited risks early, guide treatment decisions, and protect your family’s health. At Fred Hutch Cancer Center, we offer expert genetic ...

The UK National Screening Committee (NSC) has advised against universal prostate cancer screening, saying routine testing is “likely to cause more harm than good.” However, it proposed targeted ...

Prostate cancer is the most common cancer affecting American men other than skin cancer and the second leading cause of male cancer deaths. The American Cancer Society estimates that about 313,780 men ...

Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug Administration (FDA). Vanquish is a transurethral, ultrasound and ...